SEOUL: South Korea on Friday (Sep 17) permitted drugmaker Celltrions’ antibody COVID-19 remedy for contaminated adults in high-risk teams or these with extreme signs.
Section III scientific trials confirmed that the remedy considerably lowered deterioration of COVID-19 signs to extreme ranges and shortened restoration, the Ministry of Meals and Drug Security mentioned in an announcement on Friday.
The remedy lowered the speed of high-risk sufferers creating extreme signs by 72 per cent and shortened restoration by 4.12 days, the ministry mentioned.
Comments are closed.